Press Releases

Date	Title and Summary	Additional Formats
Dec 12, 2019	Fluidigm Named to Greater Toronto's Top Employers for 2020 Competition Recognizes Employers with Exceptional HR Programs and Forward-Thinking Workplace Policies SOUTH SAN FRANCISCO, Calif. , Dec. 12, 2019 (GLOBE NEWSWIRE) -- Fluidigm Canada, a subsidiary of Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to
Dec 10, 2019	Fluidigm Expands Maxpar Antibody Portfolio for High-Multiplex Tissue Imaging Delivering the Largest Commercially Available Collection of Pathologist‑Verified Antibodies for Imaging Mass Cytometry SOUTH SAN FRANCISCO, Calif. , Dec. 10, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), the global leader in high-multiplex single-scan tissue imaging, today announced
Dec 09, 2019	Fluidigm Receives Life Science Industry Award for the Maxpar Direct Immune Profiling System 2019 Gold Award for Best New Product in Cell Biology Awarded to Fluidigm SOUTH SAN FRANCISCO, Calif. , Dec. 09, 2019 (GLOBE NEWSWIRE) -- BioInformatics Inc. , the leading research and advisory firm serving the life science tools market, recognized Fluidigm (NASDAQ:FLDM) with the Gold Award for the
Nov 20, 2019	Fluidigm Corporation Announces Pricing of Private Offering of $50 Million of 5.25% Convertible Senior Notes SOUTH SAN FRANCISCO, Calif. , Nov. 20, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the pricing of $50 million aggregate principal amount of 5.25%
Nov 20, 2019	Fluidigm Corporation Announces Proposed Private Offering of $45 Million of Convertible Senior Notes SOUTH SAN FRANCISCO, Calif. , Nov. 20, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it intends to offer, subject to market conditions and other
Nov 13, 2019	Fluidigm to Participate in the 31st Annual Piper Jaffray Healthcare Conference SOUTH SAN FRANCISCO, Calif. , Nov. 13, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that the company’s management will participate in the 31st Annual Piper
Nov 05, 2019	Fluidigm Announces Third Quarter 2019 Financial Results Third quarter revenue decreased 8.5 percent to $26.5 million ; year-to-date revenue increased 5 percent to $84.8 million Third quarter consumables revenue increased 11 percent Year-to-date mass cytometry revenue increased 28 percent More than 10 new products commercialized in the quarter SOUTH SAN
Nov 05, 2019	Fluidigm Drives a New Standard in Human Immune Profiling More than 100 Academic, Pharmaceutical and Biotech Companies Select Maxpar Immune Profiling Panels Using CyTOF Technology to Accelerate Translational and Clinical Research SOUTH SAN FRANCISCO, Calif. , Nov. 05, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced it has
Oct 15, 2019	Fluidigm Showcases RNA Sequencing Innovations Using Microfluidics Technology at the 2019 American Society of Human Genetics (ASHG) Meeting Delivering automated RNA workflows to significantly reduce cost per sample and hands-on time using microfluidics technology SOUTH SAN FRANCISCO, Calif. , Oct. 15, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life
Oct 10, 2019	Fluidigm Announces Conference Call and Webcast of Third Quarter 2019 Financial Results SOUTH SAN FRANCISCO, Calif. , Oct. 10, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that it will report third quarter 2019 financial results on Tuesday,